West Pharmaceutical Services Competitive Intelligence & Landscape

West Pharmaceutical Services (westpharma.com) is a leading provider of innovative, high-quality injectable solutions and services for the pharmaceutical industry worldwide. The company is dedicated to ensuring the safe and effective containment and delivery of life-saving and life-enhancing medicines for patients globally, partnering with both established and emerging drug developers [https://westpharma.com/].

West Pharmaceutical Services offers a range of core products and services including vial containment solutions, prefillable syringes, self-injection devices, vial transfer devices, cartridge components, and analytical services [https://www.westpharma.com/support/contact-us]. The company's mission is to contain and deliver injectable therapies that improve patient lives, with a vision to be the world leader in the integrated containment and delivery of injectable medicines [https://www.westpharma.com/about-west/our-values].

Headquartered in Exton, PA, West Pharmaceutical Services, Inc., operates its global headquarters at 530 Herman O. West Drive, Exton, PA 19341 [https://www.westpharma.com/global-locations]. The company employs approximately 10,000 team members across 50 sites worldwide, shipping about 41 billion components and devices annually to support its customers [https://westpharma.com/].

West Pharmaceutical Services is publicly traded on the NYSE under the ticker WST [https://investor.westpharma.com/].

With a strong commitment to quality, collaboration, service, and innovation, West Pharmaceutical Services emphasizes its values: Passion for Customers, Leadership in Quality, and One West Team [https://www.westpharma.com/about-west/our-values]. The company has a long history, celebrating 100 years of being

West Pharmaceutical Services (westpharma.com) offers a range of pharmaceutical packaging and delivery systems, with an emphasis on injectable solutions and services. While specific pricing plans are not openly published on the website, customers can access a curated product catalog and place orders through West's Online Store. The Online Store facilitates the purchase of small quantities of high-quality, ready-to-use products, with credit card payments accepted (American Express, Visa, Mastercard) [https://www.westpharma.com/blog/2019/february/introducing-wests-online-store]. Quotations provided by West have a validity period, typically 30 days from issuance or as specified within the quote [https://www.westpharma.com/terms-and-conditions].

Customers can register for a 'My Account' to gain access to tailored product viewing and ordering [https://www.westpharma.com/shop/product-catalog]. This account also provides free features such as real-time order tracking, easily accessible quality certifications, and reordering capabilities [https://www.westpharma.com/shop]. The company offers solutions like West Ready Pack® containment system, which provides pre-assembled, ready-to-use stoppers, seals, and vials to ensure component compatibility and speed time to market [https://www.westpharma.com/products/vial-containment-solutions/ready-to-use-sterile-packaging]. These Ready Pack® solutions are available in small packs with maximum order quantities up to 10,000 pieces, typically shipped within 2-5 days [http://www.westpharma.com/-/media/WestPharma/Files/Products/Online-Store-Ready-Pack-One-Page.pdf].

Another key offering is the AccelTRA® Primary Container Closure Systems, which provide a modern elastomeric formulation with quick and reliable lead times, designed to suit a broad range of market needs and minimize delays [https://www.westpharma.com/products/vial-containment-solutions/acceltra-parenteral-drug-delivery-packaging-solutions]. The company also provides a complete portfolio of vial containment solutions, including both glass and polymer options from various manufacturers like Daikyo Crystal Zenith®, Corning® Valor® Glass, SCHOTT adaptiQ®, and SG EZ-fill [https://westpharma.com/products/vial-containment-solutions/vials]. The emphasis is on providing high-quality components that promote the efficiency, reliability, and safety of the pharmaceutical drug supply [https://www.westpharma.com/products].

West Pharmaceutical Services (westpharma.com) is actively hiring across various functions and locations, signaling a strategic focus on expanding its global operations and enhancing its technological capabilities. The company emphasizes a "purpose-led culture" where unique expertise and curiosity are valued, and its careers site highlights opportunities for individuals who want to contribute to global healthcare delivery [https://careers.westpharma.com/]. With approximately 10,000 team members across 50 sites worldwide, West Pharmaceutical Services continues to seek talent to support its role in improving patient care and treatment [https://careers.westpharma.com/].

Recent job postings indicate a demand for roles in manufacturing, quality, and technical support. Examples include "Production Operator" positions in Kinston, North Carolina [https://careers.westpharma.com/job/Kinston-Production-Operator-Nort/1389681733/], and various manufacturing and maintenance roles in locations such as Walker, Michigan, and Tempe, Arizona [https://careers.westpharma.com/go/Manufacturing-and-Quality/4959501/]. These openings suggest ongoing investment in production capacity and operational efficiency. The company also advises job seekers to "Be Aware of Recent Recruitment Scams," indicating a proactive approach to protecting potential candidates [https://www.westpharma.com/careers].

Beyond manufacturing, West Pharmaceutical Services is also recruiting for corporate and specialized roles. Notable positions at its global headquarters in Exton, Pennsylvania, include a "VP, ERP & Digital Manufacturing Solutions" [https://careers.westpharma.com/job/Exton-VP%2C-ERP-&-Digital-Manufacturing-Solutions-PA-19341/1402096633/], a "Senior Manager, Regulatory Affairs" [https://careers.westpharma.com/job/Exton-Senior-Manager%2C-Regulatory-Affairs-PA-19341/1405092533/], and an "Associate, Global Talent Acquisition" (a fixed-term hybrid contract) [https://careers.westpharma.com/job/Exton-Associate%2C-Global-Talent-Acquisition-PA-19341/1402604233/]. These diverse openings, particularly in digital manufacturing and regulatory affairs, point towards a strategic emphasis on technological advancement, compliance, and talent development within the organization.

The consistent hiring for manufacturing, technical, and high-level corporate roles, with a focus on both specific regional needs and global strategic initiatives, suggests that West Pharmaceutical Services is in a growth phase. The company's commitment to improving patient health worldwide is reflected in its continuous need for skilled professionals across its operations and R&D centers. There are no indications of significant layoffs; instead, the hiring patterns signal an expansion and enhancement of its capabilities in drug packaging and delivery solutions globally.

As a publicly traded company, West Pharmaceutical Services (westpharma.com) is listed on the NYSE under the ticker symbol WST. On July 8, 2026, the company's stock was trading at $352.99 per share [investor.westpharma.com].

West Pharmaceutical Services reported strong financial performance for various periods. In the first quarter of 2026, net sales reached $844.9 million, marking a 21.0% increase, with organic growth at 15.3%. Diluted earnings per share (EPS) surged by 56.1% to $1.92, and adjusted-diluted EPS increased by 46.9% to $2.13. Operating cash flow for the quarter was $89.9 million [investor.westpharma.com/news-releases/news-release-details/west-reports-first-quarter-2026-results]. For the full year 2025, the company anticipated net sales in the range of $3.040 billion [investor.westpharma.com/news-releases/news-release-details/west-announces-second-quarter-2025-results-and-fourth-quarter]. Fourth-quarter 2025 net sales were $805.0 million, an increase of 7.5%, with organic growth of 3.3%. Diluted EPS for the fourth quarter was $1.82, a 2.2% increase, and adjusted-diluted EPS was $2.04, up 12.1% [investor.westpharma.com/news-releases/news-release-details/west-reports-fourth-quarter-and-full-year-2025-results]. In the fourth quarter of 2024, net sales were $748.8 million, growing 2.3% with organic net sales increasing 3.3% [investor.westpharma.com/news-releases/news-release-details/west-announces-fourth-quarter-and-full-year-2024-results].

The company's financial documents, including annual and quarterly filings, as well as reports on mergers and acquisitions, are accessible through its investor relations website [investor.westpharma.com/financial].

West Pharmaceutical Services consistently details its financial condition and results of operations in its filings, providing transparency into its financial health and strategic activities [investor.westpharma.com/static-files/1c239b8a-57d9-4171-9501-7ae99541175f].

West Pharmaceutical Services serves a global customer base that includes major biologic, generic, and pharmaceutical drug companies, incorporating their components into injectable products [investor.westpharma.com/static-files/69c0483c-3830-4712-85a6-d583e60e79dd]. With approximately 10,000 team members across 50 sites worldwide, the company annually ships about 41 billion components and devices, solidifying its position as a leading global manufacturer in containment and delivery solutions for injectable medicine [westpharma.com].

West Pharmaceutical Services actively engages with the industry and its investors through various events and presentations. The company participates in significant investor conferences, such as the William Blair Annual Growth Stock Conference and the 44th Annual J.P. Morgan Healthcare Conference, where it shares updates and insights investor.westpharma.com/event-and-presentations. They also hold investor conference calls, like the Second-Quarter 2026 Conference Call, to discuss financial performance and future outlook investor.westpharma.com/event-and-presentations.

Beyond investor relations, West Pharmaceutical Services is a regular participant in industry-specific events and forums. For instance, they attend events such as the PDA Visual Inspection Forum, showcasing their latest offerings and capabilities westpharma.com/news-and-events/virtual-events. The company also announced the launch of its West Synchrony™ Prefillable Syringe System at CPHI Worldwide in Frankfurt, Germany investor.westpharma.com/news-releases/news-release-details/west-synchronytm-prefillable-syringe-system-launches-cphi.

West Pharmaceutical Services hosts a variety of webinars to provide industry knowledge and insights. These webinars, led by West experts, cover crucial topics such as selecting prefillable syringe systems, innovations in on-body drug delivery, and primary packaging for high-value biologics westpharma.com/news-and-events/webinar. A library of on-demand webinars is also available, allowing professionals to stay current on regulations, trends, and product innovations in injectable packaging and drug delivery solutions westpharma.com/news-and-events/webinar.